Menu
Search
Home > Courses > Immune Activation in Treated HIV Infection: Does It Still Matter?

Immune Activation in Treated HIV Infection: Does It Still Matter?

Immune Activation in Treated HIV Infection: Does It Still Matter?
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 11/9/2018
Review Date: 2/8/2019
Presenter
  • Peter W. Hunt, MD
    Associate Professor of Medicine
    HIV/AIDS Division University of California, San Francisco, CA
Presenter Bio
Peter Hunt, MD

Peter Hunt, MD primary research focus is on the inflammatory consequences of HIV infection. His translational research program seeks to understand both the causes and consequences of persistent immune activation in treated HIV infection, including its impact on age-related morbidity and mortality as well as HIV persistence. He also conducts pilot clinical trials of novel immune-based interventions designed to decrease immune activation and recently completed a term as Chair of the Inflammation Committee of the AIDS Clinical Trials Group (ACTG). His laboratory’s more recent work has focused on the impact of the inflammatory state on vaccine responsiveness and on the contribution of asymptomatic CMV infection to multiple inflammatory pathways in treated HIV infection. This latter work has led to a large clinical trial in the ACTG (A5383) and multiple linked NIH grants.

Continuing Education Credit (The CE accreditation for this course has expired - this section is only for your information)

This CME activity was approved for AMA PRA Category 1 Credit on October 9, 2018 and will terminate October 8, 2021.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Peter Hunt (Presenter) has had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Grant support from Gilead; Consultant to Gilead, and ViiV; Honorarium from Janssen. Dr. Hunt submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules